-
1由 Cheng, Kevin, Coller, Kelly E., Marohnic, Christopher C., Pfeiffer, Zachary A., Fino, James R., Elsing, Randee R., Bergsma, Janet, Marcinkus, Marilee A., Kar, Alak K., Gumbs, Orlando H., Otis, Kathy S., Fishpaugh, Jeffrey, Schultz, Phillip W., Pope, Mark R., Narvaez, Alfredo R., Wong, Susan J., Madison-Antenucci, Susan, Leary, Thomas P., Dawson, George J.“...A fully automated prototype B. microti antibody test was developed on the Architect instrument. The specificity was determined to be 99.98% in volunteer blood donors (n = 28,740) from areas considered to have low endemicity for B. microti. ...”
出版 2018
獲取全文
獲取全文
獲取全文
Online Artículo Texto -
2由 Butler, Emily K., Rodgers, Mary A., Coller, Kelly E., Barnaby, Devin, Krilich, Elizabeth, Olivo, Ana, Cassidy, Michael, Mbanya, Dora, Kaptue, Lazare, Ndembi, Nicaise, Cloherty, Gavin“...Samples were screened for HDV antibodies on the Abbott ARCHITECT instrument and for HDV RNA on the Abbott m2000 instrument by research assays. ...”
出版 2018
獲取全文
獲取全文
獲取全文
Online Artículo Texto -
3Hepatitis C virus surveillance and identification of human pegivirus 2 in a large Cameroonian cohort由 Rodgers, Mary A., Holzmayer, Vera, Vallari, Ana, Olivo, Ana, Forberg, Kenn, Fuhrman, Jill, Coller, Kelly E., Awazi, Bih, Kenmegne Sidje, Jules Bertrand, Frankel, Matthew B., Berg, Michael G., Mbanya, Dora, Ndembi, Nicaise, Cloherty, Gavin A.“...All specimens were screened for HCV using the Abbott RealTime HCV viral load assay and positive specimens with remaining volume were also screened for HPgV‐2 antibodies on the Abbott ARCHITECT instrument, followed by molecular characterization. ...”
出版 2018
獲取全文
獲取全文
獲取全文
Online Artículo Texto -
4Development and performance of prototype serologic and molecular tests for hepatitis delta infection由 Coller, Kelly E., Butler, Emily K., Luk, Ka-Cheung, Rodgers, Mary A., Cassidy, Michael, Gersch, Jeffrey, McNamara, Anne L., Kuhns, Mary C., Dawson, George J., Kaptue, Lazare, Bremer, Birgit, Wedemeyer, Heiner, Cloherty, Gavin A.“...Prototype molecular (RNA) and serologic (IgG) assays were developed for high-throughput testing on the Abbott m2000 and ARCHITECT systems, respectively. RNA detection was achieved through amplification of a ribozyme region target, with a limit of detection of 5 IU/ml. ...”
出版 2018
獲取全文
獲取全文
獲取全文
Online Artículo Texto
